Expression of human insulin gene wrapped with chitosan nanoparticles in NIH3T3 cells and diabetic rats

Acta Pharmacologica Sinica

Volumn 29, Issue 11, 2008, Pages 1342-1349

  Niu, Li ^a   Xu, Yan Cheng ^a   Xie, Hai Ying ^a   Dai, Zhe ^a   Tang, Hui Qin ^a  

^a WUHAN UNIVERSITY   (China)

Author keywords

Chitosan nanoparticle; Diabetes mellitus; Gene expression; Human insulin gene

Indexed keywords

CHITOSAN; HUMAN INSULIN; NANOPARTICLE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL STRAIN 3T3; CONTROLLED STUDY; DIABETES MELLITUS; EXPRESSION VECTOR; GENE EXPRESSION; GENETIC TRANSFECTION; GLUCOSE BLOOD LEVEL; INSULIN BLOOD LEVEL; MALE; NONHUMAN; RAT;

ANIMALS; CHITOSAN; CYTOMEGALOVIRUS; DIABETES MELLITUS, EXPERIMENTAL; DIABETES MELLITUS, TYPE 1; GENE THERAPY; GENE TRANSFER TECHNIQUES; GENETIC VECTORS; HUMANS; INSULIN; MALE; MICE; NANOPARTICLES; NIH 3T3 CELLS; PLASMIDS; RATS; RATS, WISTAR; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION;

EID: 55149124541     PISSN: 16714083     EISSN: 17457254     Source Type: Journal    
DOI: 10.1111/j.1745-7254.2008.00888.x     Document Type: Article

References (41)

1. Bell DS. Insulin therapy in diabetes mellitus: how can the currently available injectable insulins be most prudently and efficaciously utilised Drugs 2007 67 : 1813 27.
2. Dieterle C, Brendel MD, Seissler J, Eckhard M, Bretzel RG, Landgraf R. Therapy of diabetes mellitus. Pancreas transplantation, islet transplantation, stem cell and gene therapy. Internist (Berl) 2006 47 : 489 96.
3. Samson SL, Chan L. Gene therapy for diabetes: reinventing the islet. Trends Endocrinol Metab 2006 17 : 92 100.
4. Giannoukakis N, Trucco M. Gene therapy for type 1 diabetes. Am J Ther 2005 12 : 512 28.
5. Zaia JA. The status of gene vectors for the treatment of diabetes. Cell Biochem Biophys 2007 48 : 183 90.
6. Prud'homme GJ, Glinka Y, Khan AS, Draghia-Akli R. Electroporation- enhanced nonviral gene transfer for the prevention or treatment of immunological, endocrine and neoplastic diseases. Curr Gene Ther 2006 6 : 243 73.
7. Chaszczewska-Markowska M, Stebelska K, Sikorski A, Madej J, Opolski A, Ugorski M. Liposomal formulation of 5-fluorocytosine in suicide gene therapy with cytosine deaminase for colorectal cancer. Cancer Lett 2008 262 : 164 72.
8. Bajaj A, Kondaiah P, Bhattacharya S. Gene transfection efficacies of novel cationic gemini lipids possessing aromatic backbone and oxyethylene spacers. Biomacromolecules 2008 9 : 991 9.
9. Kim HS, Kim JS, Lee YK, Koo KH, Park YS. An efficient liposomal gene delivery vehicle using Sendai F/HN proteins and protamine. Cancer Gene Ther 2008 15 : 214 24.
10. Turner P, Petch A, Al-Rubeai M. Encapsulation of viral vectors for gene therapy applications. Biotechnol Prog 2007 23 : 423 9.
11. Miyazaki M, Obata Y, Abe K, Furusu A, Koji T, Tabata Y, et al. Gene transfer using nonviral delivery systems. Perit Dial Int 2006 26 : 633 40.
12. Ragusa A, Garcia I, Penades S. Nanoparticles as nonviral gene delivery vectors. IEEE Trans Nanobiosci 2007 6 : 319 30.
13. Schmitz T, Bravo-Osuna I, Vauthier C, Ponchel G, Loretz B, Bernkop-Schniirch A. Development and in vitro evaluation of a thiomer-based nanoparticulate gene delivery system. Biomaterials 2007 28 : 524 31.
14. Ren B, O'Brien BA, Swan MA, Koina ME, Nassif N, Wei MQ, et al. Long-term correction of diabetes in rats after lentiviral hepatic insulin gene therapy. Diabetologia 2007 50 : 1910 20.
15. Fodor A, Harel C, Fodor L, Armoni M, Salmon P, Trono D, et al. Adult rat liver cells transdifferentiated with lentiviral IPF1 vectors reverse diabetes in mice: an ex vivo gene therapy approach. Diabetologia 2007 50 : 121 30.
16. Mao HQ, Roy K, Troung-Le VL, Janes KA, Lin KY, Wang Y, et al. Chitosan-DNA nanoparticles as gene carriers: synthesis, characterization and transfection efficiency. J Control Release 2001 70 : 399 421.
17. Shapiro AM, Lakey JR, Ryan EA, Korbutt GS, Toth E, Warnock GL, et al. Islet transplantation in seven patients with type 1 diabetes mellitus using a glucocorticoid-free immunosuppressive regimen. N Engl J Med 2000 343 : 230 8.
18. Lau J, Nyqvist D, Köhler M, Berggren PO, Jansson L, Carlsson PO. Implantation site-dependent dysfunction of transplanted pancreatic islets. Diabetes 2007 56 : 1544 50.
19. Li M, Inaba M, Guo KQ, Hisha H, Abraham NG, Ikehara S. Treatment of streptozotocin-induced diabetes mellitus in mice by intra-bone marrow bone marrow transplantation plus portal vein injection of beta cells induced from bone marrow cells. Int J Hematol 2007 86 : 438 45.
20. Sutherland DE, Gruessner RW, Dunn DL, Matas AJ, Humar A, Kandaswamy R, et al. Lessons learned from more than 1,000 pancreas transplants at a single institution. Ann Surg 2001 233 : 463 501.
21. Socci C, Orsenigo E, Zuber V, Caldara R, Castoldi R, Parolini D, et al. Triple arterial reconstruction improves vascularization of whole pancreas for transplantation. Transplant Proc 2006 38 : 1158 9.
22. Vaca P, Berná G, Araujo R, Carneiro EM, Bedoya FJ, Soria B, et al. Nicotinamide induces differentiation of embryonic stem cells into insulin-secreting cells. Exp Cell Res 2008 314 : 969 74.
23. Brenner S, Ryser MF, Whiting-Theobald NL, Gentsch M, Linton GF, Malech HL. The late dividing population of gamma-retroviral vector transduced human mobilized peripheral blood progenitor cells contributes most to gene-marked cell engraftment in nonobese diabetic/severe combined immunodeficient mice. Stem Cells 2007 25 : 1807 13.
24. Timper K, Seboek D, Eberhardt M, Linscheid P, Christ-Crain M, Keller U, et al. Human adipose tissue-derived mesenchymal stem cells differentiate into insulin, somatostatin, and glucagon expressing cells. Biochem Biophys Res Commun 2006 341 : 1135 40.
25. Fukushima M, Hattori Y, Tsukada H, Koga K, Kajiwara E, Kawano K, et al. Adiponectin gene therapy of streptozotocin-induced diabetic mice using hydrodynamic injection. J Gene Med 2007 9 : 976 85.
26. Yoo HS, Mazda O, Lee HY, Kim JC, Kwon SM, Lee JE, et al. In vivo gene therapy of type I diabetic mellitus using a cationic emulsion containing an Epstein Barr Virus (EBV) based plasmid vector. J Control Release 2006 112 : 139 44.
27. Lu YC, Sternini C, Rozengurt E, Zhukova E. Release of transgenic human insulin from gastric g cells: a novel approach for the amelioration of diabetes. Endocrinology 2005 146 : 2610 9.
28. Cho YM, Lim JM, Yoo DH, Kim JH, Chung SS, Park SG, et al. Betacellulin and nicotinamide sustain PDX1 expression and induce pancreatic beta-cell differentiation in human embryonic stem cells. Biochem Biophys Res Commun 2008 366 : 129 34.
29. Jafary H, Larijani B, Farrokhi A, Pirouz M, Mollamohammadi S, Baharvand H. Differential effect of activin on mouse embryonic stem cell differentiation in insulin-secreting cells under nestin-positive selection and spontaneous differentiation protocols. Cell Biol Int 2008 32 : 278 86.
30. Serafimidis I, Rakatzi I, Episkopou V, Gouti M, Gavalas A. Novel effectors of directed and Ngn3-mediated differentiation of mouse embryonic stem cells into endocrine pancreas progenitors. Stem Cells 2008 26 : 3 16.
31. D'Anneo A, Rood P, Bottino R, Balamurugan AN, He J, Giannoukakis N. Gene therapy for type 1 diabetes: is it ready for the clinic Immunol Res 2006 36 : 83 9.
32. Douglas KL, Piccirillo CA, Tabrizian M. Effects of alginate inclusion on the vector properties of chitosan-based nanoparticles. J Control Release 2006 115 : 354 61.
33. Köping-Höggård M, Issa MM, Köhler T, Tronde A, Vårum KM, Artursson P. A miniaturized nebulization catheter for improved gene delivery to the mouse lung. J Gene Med 2005 7 : 1215 22.
34. Koya V, Lu S, Sun YP, Purich DL, Atkinson MA, Li SW, et al. Reversal of streptozotocin-induced diabetes in mice by cellular trans-duction with recombinant pancreatic transcription factor pancreatic duodenal homeobox-1: a novel protein transduction domain-based therapy. Diabetes 2008 57 : 757 69.
35. Okamoto R, Watanabe M. Molecular and clinical basis for the regeneration of human gastrointestinal epithelia. J Gastroenterol 2004 39 : 1 6.
36. Cani PD, Hoist JJ, Drucker DJ, Delzenne NM, Thorens B, Burcelin R, et al. GLUT2 and the incretin receptors are involved in glucose-induced incretin secretion. Mol Cell Endocrinol 2007 276 : 18 23.
37. Cheung AT, Dayanandan B, Lewis JT, Korbutt GS, Rajotte RV, Bryer-Ash M, et al. Glucose-dependent insulin release from genetically engineered K cells. Science 2000 290 : 1959 62.
38. Palizban AA, Salehi R, Nori N, Galehdari H. In vivo transfection rat small intestine K-cell with pGIP/Ins plasmid by DOTAP liposome. J Drug Target 2007 15 : 351 7.
39. Cassidy RS, Irwin N, Flatt PR. Effects of gastric inhibitory poly-peptide (GIP) and related analogues on glucagon release at normo-and hyperglycaemia in Wistar rats and isolated islets. Biol Chem 2008 389 : 189 93.
40. Kuo P, Chaikomin R, Pilichiewicz A, O'Donovan D, Wishart JM, Meyer JH, et al. Transient, early release of glucagon-like peptide-1 during low rates of intraduodenal glucose delivery. Regul Pept 2008 146 : 1 3.
41. McClean PL, Gault VA, Irwin N, McCluskey JT, Flatt PR. Daily administration of the GIP-R antagonist (Pro3)GIP in streptozotocin-induced diabetes suggests that insulin-dependent mechanisms are critical to anti-obesity-diabetes actions of (Pro3)GIP. Diabetes Obes Metab 2008 10 : 336 42.